Heart and kidney failure often co-exist and confer high morbidity and mortality. The complex
bi-directional nature of heart and kidney dysfunction is referred to as cardiorenal syndrome …

Sodium-glucose cotransporter type 2 inhibitors (SGLT2is) are new oral glucose-lowering
agents that provide cardiovascular and renal protection in both patients with and without …

Cardiac surgery‐associated acute kidney injury (CSA‐AKI) is a major and serious
complication in patients undergoing cardiac surgery and is independently associated with …

Acute heart failure constitutes a heterogeneous clinical syndrome, whose pathophysiology
is complex and not completely understood. Given the diversity of clinical presentations …

Renin-angiotensin-aldosterone system (RAAS) blockers and sodium-glucose cotransporter
type 2 inhibitors (SGLT2is) are two pharmacological classes that proved a remarkable …

Background In acute decompensated heart failure (ADHF) the risk of acute kidney injury
(AKI) is high. Early detection of patients at risk for AKI is important. We tested urinary [TIMP …

Sodium–glucose co-transporter 2 inhibitors (SGLT2is) reduce albuminuria and hard renal
outcomes (decline of renal function, renal replacement therapy and renal death) in patients …

La insuficiencia cardiaca aguda es un síndrome clínico heterogéneo, cuya fisiopatología es
compleja y no se conoce por completo. Dada la diversidad de formas de presentación …

The interaction between acute heart failure (AHF) and renal dysfunction is complex. Several
studies have evaluated the prognostic value of this syndrome. The aim of this systematic …

Introduction Sodium-glucose co-transporter type 2 inhibitors (SGLT2is) were developed as
glucose-lowering agents for the management of type 2 diabetes (T2D). Unexpectedly, they …